Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D.
Ayala G, et al. Among authors: miles bj.
Mol Ther. 2006 Apr;13(4):716-28. doi: 10.1016/j.ymthe.2005.11.022. Epub 2006 Feb 15.
Mol Ther. 2006.
PMID: 16480930
Free article.
Clinical Trial.